Isaac Kofi Owusu

Dr. Isaac Kofi Owusu

Auto-generated profile, based on publicly available information

Dr. Isaac Kofi Owusu


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
KBKwadwo Osei Bonsu
Kwadwo Osei Bonsu
IOIsaac Kofi Owusu
Isaac Kofi Owusu
KBKwame Ohene Buabeng
Kwame Ohene Buabeng
DRDaniel D. Reidpath
Daniel D. Reidpath
AKAmudha Kadirvelu
Amudha Kadirvelu

3 February 2026 in Circulation
Verified
Journal Article
Closed access
AOAlexis K. Okoh
Alexis K. Okoh
LALambert T. Appiah
Lambert T. Appiah
YWYaw A. Wiafe
Yaw A. Wiafe
MAMichael K. Amponsah
Michael K. Amponsah
SFSetri S. Fugar
Setri S. Fugar
MOModele O. Ogunniyi
Modele O. Ogunniyi

1 January 2024 in Clinical Medicine Insights: Case Reports
Verified
Journal Article
Open access
IOIsaac Kofi Owusu
Isaac Kofi Owusu
GAGordon Manu Amponsah
Gordon Manu Amponsah
YWYaw Amo Wiafe
Yaw Amo Wiafe
Most individuals with ventricular septal defect survive to adulthood which allows time for other complications such as pulmonary arterial hypertension to gradually develop over a period of time. When there are other associated cardiac conditions that also contribute to the development of pulmonary hypertension such as valvular heart disease, the pulmonary hypertension may be exaggerated. Because these different etiologies of the pulmonary hypertension have different mechanisms, their coexistence can complicate patient management. We present a 26-year-old man with a large ventricular septal defect and rheumatic mitral valve disease who developed severe pulmonary hypertension that became complicated by atrial fibrillation and later sudden cardiac death.

1 October 2022 in Research Reports in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
IOIsaac Kofi Owusu
Isaac Kofi Owusu
EAEmmanuel Acheamfour-Akowuah
Emmanuel Acheamfour-Akowuah
YWYaw Amo Wiafe
Yaw Amo Wiafe
Background: Rheumatic heart disease (RHD) is mainly among populations in low-to-middle income nations. The burden of this disease on communities and even hospital settings is little understood. This study aimed at analysing the clinical and socio-demographic features of RHD patients in our adult outpatient cardiac department over a 3-year period. Methods: The study was conducted at the Komfo Anokye Teaching Hospital’s Adult Cardiac Clinic in Kumasi, Ghana. Medical records of patients seen at the adult cardiac clinic between 2016 and 2019 with the diagnosis of rheumatic heart disease were examined. The data were captured using EPI-DATA (version 3.1). Stata 14 was used in analysing the mean (standard deviation) and median of continuous variables (inter-quartile range). The frequency and percentages were used to describe categorical data. The Chi-square test was used to establish the statistical significance of a relationship, with a p-value of less than 0.05. Results: A total of 140 RHD cases were included in the study. The average age of patients was 39.7 years. Majority of the participants (82.9%) were from rural areas. Palpitation was the commonest symptom (54.29%), followed by chest pains (36.43%), dyspnoea (25.00%), and dizziness (24.29%). Over seventy-seven percent (77.14%) of the patients had moderate-to-severe rheumatic heart disease. The commonest valvular lesion was isolated mitral regurgitation (56.43%), followed by pure aortic regurgitation (30.71%), and isolated tricuspid regurgitation (12.14%). Conclusion: RHD occurred more commonly in the third decade of life. Rural participants, who are primarily females, were the most affected. Efforts to reduce prevalence rates should be stepped up.

1 January 2024 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
MWManasseh Bannor Wireko
Manasseh Bannor Wireko
JHJacobus Hendricks
Jacobus Hendricks
KBKweku Bedu-Addo
Kweku Bedu-Addo
MSMarlise Van Staden
Marlise Van Staden
ENEmmanuel A. Ntim
Emmanuel A. Ntim
IOIsaac K. Owusu
Isaac K. Owusu
Background: The effect of hypertension is aggravated by lifestyle factors such as alcohol consumption. This study sought to determine the association between alcohol consumption and the level of blood pressures among HIV seronegative and seropositive cohorts. Methods: This secondary analysis was performed on a cross-sectional survey data of 17 922 participants during the period between 2018 and 2020. A questionnaire was used to obtain participants’ alcohol consumption history, which was categorized into non-alcohol consumers, non-heavy alcohol consumers, and heavy alcohol consumers. A linear regression model was used to establish relationships among participants with raised blood pressure (BP ≥ 140/90 mmHg). Results: Out of the total participants, 3553 (19.82%) were hypertensives. Almost 13% of the hypertensives (n = 458; 12.89%) were undiagnosed, and 12.44 % (442) had uncontrolled hypertension. About 14.52% of the hypertensives (3553) were not on any antihypertensive medication. Male non-consumers of alcohol had the highest systolic and diastolic BP; uncontrolled systolic BP (165.53 ± 20.87 mmHg), uncontrolled diastolic BP (102.28 ± 19.21mmHg). Adjusted for covariates, moderate alcohol consumption was associated with HTN among participants who were HIV seropositive [unadjusted (RR = 1.772, P = .006, 95% CI (1.178-2.665)], [RR = 1.772, P = .005, 95% CI (1.187-2.64)]. [unadjusted RR = 1.876, P = .036, 95% CI (1.043-3.378)], adjusted RR = 1.876, P = .041, 95% CI (1.024-3.437). Both moderate and heavy alcohol consumption were significantly related to hypertension among HIV sero-negative [unadjusted model, moderate consumption RR = 1.534 P = .003, 95% CI (1.152-2.044)], [adjusted model, moderate alcohol consumption RR = 1.535, P = .006, 95% CI (1.132-2.080)], [unadjusted model, heavy alcohol consumption, RR = 2.480, P = .030, 95% CI (1.091-5.638)], [adjusted model RR = 2.480, P = .034, 95% CI (1.072-5.738)]. Conclusion: Alcohol consumption is significantly related to increase BP regardless of HIV infection.

1 June 2022 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
IOIsaac Kofi Owusu
Isaac Kofi Owusu
YWYaw Amo Wiafe
Yaw Amo Wiafe
SOStephen Opoku
Stephen Opoku
Enoch Odame ANTOEnoch Odame ANTO
Enoch Odame ANTO
EAEmmanuel Acheamfour-Akowuah
Emmanuel Acheamfour-Akowuah
Purpose: This study determined electrocardiographic and echocardiographic abnormalities of people living with HIV (PLWHIV); comparing the findings of PLWHIV on HAART versus treatment naïve groups. Patients and Methods: In a prospective cross-sectional study, we recruited 157 PLWHIV on Highly Active Antiretroviral Therapy (HAART) and 28 HAART naïve PLWHIV. Clinical examination, electrocardiography and echocardiography were performed on study participants at the Komfo Anokye Teaching Hospital (KATH) in Kumasi, Ghana. Sociodemographic data and information about the use of HAART or otherwise was obtained. The Chi and Fisher Exact tests were used to find the significance of difference in proportions of abnormalities between PLWHIV on HAART and treatment naïve groups. Statistical analyses were performed on SPSS version 25.0 and GraphPad Prism version 8.0. P-values less than 0.05 were considered to be statistically significant. Results: Echocardiographic abnormalities in the HAART and treatment naïve groups were 54.1% and 60.7%, respectively. Electrographic abnormalities in the HAART and treatment naïve groups were 45.9% and 50%, respectively. Sinus bradycardia was the most prevalent ECG abnormality in the treatment naïve. Nonspecific T-wave changes (36.1%) and sinus tachycardia (30.6%) were the most common ECG abnormalities seen in HAART treated group. The common echocardiographic abnormalities were pulmonary hypertension (22.7%), pericardial effusion (22.2%) and left ventricular systolic dysfunction (17.8%). There was no significant difference in the proportions of echocardiographic abnormalities between PLWHIV on HAART and the treatment naïve groups (p > 0.05). Conclusion: Cardiac abnormalities are common in PLWHIV regardless of treatment with HAART. Echocardiographic and electrographic assessments are highly recommended for all PLWHIV.